Clinical trial
Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
NCT00438113 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- September 30, 2016
- Enrollment
- 184 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.